Skip to main content

Table 2 Prevalence and length of respiratory support and intensive care unit admission

From: Increased bronchiolitis burden and severity after the pandemic: a national multicentric study

 

Oxygen

HFNC

NIRS

MV

ICU

Patients n (%)

Days mean ± SD

Patients n (%)

Days mean ± SD

Patients n (%)

Days mean ± SD

Patients n (%)

Days mean ± SD

Number (percentage)

Days mean ± SD

2018–2019

253 (52%)

4.1 ± 3

141 (29%)

4.1 ± 2

68 (14%)

3.6 ± 2

6 (1%)

5.2 ± 2

86 (18%)

5 ± 3.5

2019–2020

227 (57%)

4.3 ± 3

115 (29%)

4.5 ± 2

69 (17%)

3.4 ± 2

11 (2%)

5.3 ± 2

84 (21%)

5.2 ± 3.2

2020–2021

16 (47%)

3.6 ± 3

10 (29%)

3.9 ± 5

5 (15%)

2.0 ± 1

0

NA

6 (18%)

2.8 ± 1.6

2021–2022

414 (73%)

4.6 ± 3

300 (53%)

4.5 ± 2

99 (18%)

4.0 ± 3

6 (1%)

4.0 ± 3

122 (22%)

5.7 ± 3.4

2022–2023

505 (53%)

4.4 ± 3

585 (61%)

4.4 ± 3

217 (23%)

3.7 ± 2

38 (4%)

6.3 ± 5

210 (22%)

6.4 ± 6.5

P-value

p < 0.001

p = 0.18

p < 0.001

p = 0.59

p = 0.001

p = 0.29

p < 0.001

p = 0.71

p = 0.4

p = 0.068

  1. HFNC High-Flow Nasal cannula, NIRS Non-Invasive Respiratory Supports, ICU Intensive Care Unit, MV Mechanically ventilated